See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2014_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 244,405,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,844,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,846,000 |
| 3 | remainder_Assets | 2,364,000 |
| 4 | LiabilitiesCurrent | 33,121,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 59,930,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 59,010,432 |
| 9 | ResearchAndDevelopmentExpense | 18,856,856 |
| 10 | remainder_Expenses | 9,188,483 |
| 11 | remainder_Revenues | 81,312,260 |
| 12 | remainder_NetIncome | 742,463 |
| 13 | remainder_ComprehensiveNetIncome | -244,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 265,459,000 |
| 1 | Liabilities | 93,051,000 |
| 2 | Expenses | 87,055,771 |
| 3 | Revenues | 81,312,260 |
| 4 | StockholdersEquity | 172,408,000 |
| 5 | NetIncome | -5,001,048 |
| 6 | ComprehensiveNetIncome | -5,123,048 |
| 7 | BaseVar | 263,932,247 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.07 |
| 9 | EconomicCapitalRatio | 3.07 |
Edgar->Model Mapping
Feature Distribution
Change over Time
